结直肠癌免疫治疗的现状:系统性审查
Hanna Cholewa1, Pablo Guerrero-Antolino1, David Quevedo1
1Colorectal Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Cirugia espanola
|October 11, 2025
概括
免疫疗法在不同阶段的结直肠癌中显示出有前途. 然而,需要进一步的研究来优化患者选择和治疗方案,以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 结肠直肠癌研究研究
背景情况:
- 结肠直肠癌 (CRC) 仍然是一个重大的全球健康挑战.
- 免疫疗法已成为瘤学中一个有前途的治疗方式.
- 了解目前CRC免疫疗法的现状对于临床进展至关重要.
研究的目的:
- 系统地审查目前结直肠癌免疫治疗的现状.
- 评估免疫治疗在新辅助,辅助和转移环境中的疗效.
- 确定CRC的免疫疗法应用中需要改进的领域.
主要方法:
- 在PubMed,Cochrane和Embase数据库中进行全面的文献搜索,截至2024年4月.
- 纳入标准集中在英语临床研究 (发表≥2000),不包括病例报告,信件,I期试验和放射性免疫疗法.
- 使用MINORS和RoB2工具评估偏差的质量和风险,由于研究异质性而进行描述性分析.
主要成果:
- 分析了99项涉及11,226名患者的研究.
- 在结直肠癌中免疫治疗的应用表明了令人鼓舞的结果.
- 研究中的显著异质性需要仔细解释.
结论:
- 目前在结直肠癌中的免疫治疗策略需要改进.
- 优化患者选择对于最大限度地提高免疫治疗效益至关重要.
- 进一步研究适当的治疗方案对于改善临床结果至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Vaccines
960
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
960
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
488
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
488


